MedPath

LOVENOX

LOVENOX

Approved
DIN Number

02378426

Drug Class

Human

Market Date

Nov 13, 2012

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02378426
AIG Number0131860001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB05 ENOXAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENOXAPARIN SODIUMActive
Strength: 60 MG / 0.6 ML
Monograph: ENOXAPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.